Vaxine and University of Georgia Complete First Stage of COVID-19 Ferret Challenge Studies
COVAX-19® immunizations completed at University of Georgia to assess COVID-19 protection.
Vaxine Pty Ltd announced today completion of the immunization phase of ferret challenge studies being conducted at the University of Georgia to test the ability of Vaxine’s promising COVAX-19® vaccine to protect against COVID-19.
“We have already seen that COVAX-19® vaccine induces potent antibody and T cell responses against COVID-19 spike protein in mice and have seeen antibody responses in monkeys that exceeded levels in recovering human patients post-COVID-19 infection”, said Professor Nikolai Petrovsky, MBBS, FRACP, PhD, Chairman and Research Director of Vaxine.
Link to the article: